The University of Florida was recently named one of four new Pediatric Brain Tumor Consortium, or PBTC, member institutions along with the Dana-Farber Cancer Institute in Boston; Nationwide Children’s Hospital in Columbus, Ohio; and the Hospital for Sick Children in Toronto.
Established in 1999, the PBTC, which is sponsored and funded by the National Cancer Institute, combines the expertise of competitively selected institutions to develop and conduct novel clinical trials for the treatment of pediatric brain tumors.
“The PBTC has literally created a paradigm shift in the way brain tumors are treated in children and is constantly testing novel combinations and approaches to the treatment of pediatric brain tumors,” said Sridharan Gururangan, FRCP, an endowed professor in the Lillian S. Wells Department of Neurosurgery.